US Patent Issued to THE TRUSTEES OF DARTMOUTH COLLEGE on Feb. 24 for "Nucleic acid encoding NKP30 receptor targeted therapeutics" (New Hampshire Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,537, issued on Feb. 24, was assigned to THE TRUSTEES OF DARTMOUTH COLLEGE (Hanover, N.H.).

"Nucleic acid encoding NKP30 receptor targeted therapeutics" was invented by Tong Zhang (Lebanon, N.H.) and Charles L. Sentman (Grantham, N.H.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention is directed to T cells and other cells that express chimeric NK-p30 receptors ("chimeric NKp30 T cells"), methods of making and using chimeric NKp30 T cells, and methods of using these chimeric NKp30 T cells to address diseases and disorders. In one aspect, the disclosure broadly relates to chimeric NKp30 T cells, isolated populations thereof, and compositions...